Avanir Pharma (AVNR) Reports Strong Prelim. Q1 Revs
Tweet Send to a Friend
Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) announced preliminary financial information (unaudited) for the quarter-ended December 31, 2013, in anticipation of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE